Stryker recalls specific Trevo Trak 21 Microcatheter models due to missing product drawing on carton labels. This may affect medical device safety during procedures.
“Stryker Trevo Trak 21 Microcatheter: Missing Product Label Drawing.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60556-stryker-trevo-trak-21-microcatheter-missing-product-label-drawing. Based on FDA recall #Z-1386-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1386-2022%22&limit=1).
The FDA announced on June 3, 2022, that Stryker Neurovascular is voluntarily recalling Trevo Trak 21 Microcatheters because product labels are missing required illustrations, according to the FDA.
The microcatheter product label on the carton is missing the microcatheter product drawing or illustration, according to the FDA.
Context
GovInfoNow's records show Stryker Neurovascular has 16 other recalls on record since June 26, 2017. Other recent recalls of similar products include Stryker INZONE Detachment System (April 6, 2026), Stryker Trevo Trak 21 Microcatheter Recall (April 23, 2024), and Stryker CS Uni-Directional w Auto ID Catheter Recall (April 10, 2026).
How to tell if you have this one
Check for the product codes: REF 90338, 91412, 91413, 91414, 91415, SFP914170, or SFP914190. These models were sold with specific lot numbers and reference codes.
Look for the product drawing on the carton label to confirm the microcatheter model.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 16 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide distribution - US Nationwide distribution in the states of CA, OR, PA, NY, DC, IL, WA, NH, NJ, OK, FL, AZ, AL, GA, TX, WI, VA and the countries of DE, IT, AT.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arizona, California, District of Columbia, Florida, Georgia, Illinois, New Hampshire, New Jersey, New York, Oklahoma, Oregon, Pennsylvania, Texas, Virginia, Washington, Wisconsin.
Recall timeline
FDA published this recall 54 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1386-2022 (June 3, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1386-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.